This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Research article
Alexandra Butler
Qatar Biomedical Research Institute
Corresponding Author
ORCiD: https://orcid.org/0000-0002-5762-3917
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Objective To determine if vitamin D deficiency (25-hydroxyvitamin D3 (25(OH)D3)), exacerbated the cardiovascular and metabolic characteristics in women with polycystic ovary syndrome (PCOS).Design Comparative cross-sectional analysis.
Methods Demographic and metabolic data from women aged 18-40 years from the Qatar Biobank (QBB) (78 diagnosed with PCOS, 641 controls).
Results Vitamin D deficiency (median (range)) was seen in both normal 14.0 (124) ng/ml and the PCOS cohorts 14.0 (62) ng/ml and did not differ between them. Whilst PCOS subjects were heavier with a more metabolic profile (greater systolic and diastolic blood pressure, higher levels of C-reactive protein, androgens, insulin and glycosylated hemoglobin (HbA1c) and decreased high density lipoprotein (HDL) levels, with endothelial dysfunction as determined by pulse wave velocity, there was no correlation (Pearson coefficient) of any these parameters with vitamin D for either the control or PCOS population.
Conclusion Vitamin D deficiency was equally prevalent in women with and without PCOS and was not correlated to insulin resistance, metabolic or cardiovascular parameters, suggesting that vitamin D deficiency is not associated with the PCOS phenotype.
Keywords
Vitamin D, polycystic ovary syndrome, insulin resistance, androgens, cardiovascular risk
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 20 Jan, 2020
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Endocrinology & Metabolism
Learn more about our company.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Research article
Alexandra Butler
Qatar Biomedical Research Institute
Corresponding Author
ORCiD: https://orcid.org/0000-0002-5762-3917
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 20 Jan, 2020
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Endocrinology & Metabolism
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Objective To determine if vitamin D deficiency (25-hydroxyvitamin D3 (25(OH)D3)), exacerbated the cardiovascular and metabolic characteristics in women with polycystic ovary syndrome (PCOS).Design Comparative cross-sectional analysis.
Methods Demographic and metabolic data from women aged 18-40 years from the Qatar Biobank (QBB) (78 diagnosed with PCOS, 641 controls).
Results Vitamin D deficiency (median (range)) was seen in both normal 14.0 (124) ng/ml and the PCOS cohorts 14.0 (62) ng/ml and did not differ between them. Whilst PCOS subjects were heavier with a more metabolic profile (greater systolic and diastolic blood pressure, higher levels of C-reactive protein, androgens, insulin and glycosylated hemoglobin (HbA1c) and decreased high density lipoprotein (HDL) levels, with endothelial dysfunction as determined by pulse wave velocity, there was no correlation (Pearson coefficient) of any these parameters with vitamin D for either the control or PCOS population.
Conclusion Vitamin D deficiency was equally prevalent in women with and without PCOS and was not correlated to insulin resistance, metabolic or cardiovascular parameters, suggesting that vitamin D deficiency is not associated with the PCOS phenotype.
Loading...